PanaxPharm

PanaxPharm is a specialized biotechnology and pharmaceutical company based in Germany that focuses on the research, development, and production of high-purity ginsenosides derived from Panax ginseng. The company utilizes a proprietary extraction and purification technology to produce rare ginsenosides such as Rg1, Rb1, and Rg3 at pharmaceutical-grade quality. These compounds are investigated for their therapeutic potential in treating neurodegenerative disorders like Alzheimer's disease, as well as in oncology and cardiovascular health. PanaxPharm serves as both a research-driven entity exploring new drug candidates and a high-end supplier for the pharmaceutical, nutraceutical, and cosmetic industries. Their work bridges the gap between traditional herbal medicine and modern evidence-based pharmacology through rigorous standardization of active ingredients.